CRP and type 2 diabetes mellitus: These studies indicate that colchicine may reduce levels of blood glucose, glycated hemoglobin, and inflammatory markers such as CRP, demonstrating its potential for the treatment of T2DM, which is characterized by chronic inflammation [76,77,78].